BMY$62.410.11%-0.07
Bristol Myers Squibb Co (BMY)
Date: 2026-11-02 16:00O: 62.29H: 62.71L: 62.23C: 62.36Vol: 224.5k
Bristol Myers Squibb Co stock is traded at $62.41, with a volume of 736,915. It is down -0.11% in the last 24 hours and up +2.06% over the past month. Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
Previous Close:
$62.48
Open:
$62.29
24h Volume:
736,915
Relative Volume:
0.07
Market Cap:
$127.57B
Revenue:
$48.48B
Net Income/Loss:
$7.27B
P/E Ratio:
17.52
EPS:
$3.56
Net Cash Flow:
$11.91B
1W Performance:
+1.30%
1M Performance:
+2.06%
6M Performance:
+7.20%
1Y Performance:
+35.47%
1-Day Range:
$62.17$62.71
1-Week Range:
$60.00$64.05
52-Week Range:
$43.20$68.64
Bristol Myers Squibb Co Stock (BMY) Company Profile
Name
Bristol Myers Squibb CoSector
HealthcareIndustry
Drug Manufacturers - GeneralPhone
(609) 252-4621Address
ROUTE 206 AND PROVINCE LINE ROAD, PRINCETON, NY, USACompare BMY vs LLY, JNJ, ABBV, MRK, NVS
| Stocks | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|
BMY Bristol Myers Squibb Co | $127.57B | $48.48B | $7.27B | $11.91B | $3.56 |
 LLY Lilly Eli Co | $1.24T | $72.25B | $25.28B | $10.37B | $27.78 |
 JNJ Johnson Johnson | $647.40B | $97.93B | $21.04B | $17.80B | $8.63 |
 ABBV Abbvie Inc | $508.82B | $62.82B | $3.60B | $19.98B | $2.03 |
 MRK Merck Co Inc | $365.41B | $65.51B | $8.93B | $14.12B | $3.55 |
 NVS Novartis Ag Adr | $303.08B | $54.66B | $13.58B | $16.05B | $7.02 |
Bristol Myers Squibb Co Stock (BMY) Upgrades & Downgrades
Bristol Myers Squibb Co Stock (BMY) Financials Data
Bristol Myers Squibb Co Stock (BMY) Insider Trading
- Massacesi CristianSep 09 '26EVP,Chief Med Offr,Head of Dev
- Transaction
- Sale
- Cost
- $64.57
- #Shares
- 6,249
- Value ($)
- 403,498
- #Shares Total
- 18,748
- Massacesi CristianSep 09 '26Officer
- Transaction
- Proposed Sale
- Cost
- $64.57
- #Shares
- 6,249
- Value ($)
- 403,498
- #Shares Total
- 0
- Short Bartie WendySep 01 '26EVP, Corporate Affairs
- Transaction
- Option Exercise
- Cost
- $66.92
- #Shares
- 1,236
- Value ($)
- 82,713
- #Shares Total
- 13,317
- Holzer Phil MAug 25 '26Officer
- Transaction
- Proposed Sale
- Cost
- $67.50
- #Shares
- 500
- Value ($)
- 33,750
- #Shares Total
- 0
- Holzer Phil MAug 25 '26SVP and Controller
- Transaction
- Sale
- Cost
- $67.50
- #Shares
- 500
- Value ($)
- 33,750
- #Shares Total
- 16,862
- Gallman CariAug 01 '26EVP, General Counsel
- Transaction
- Option Exercise
- Cost
- $0.00
- #Shares
- 1,061
- Value ($)
- 0
- #Shares Total
- 14,192
- Massacesi CristianAug 01 '26EVP,Chief Med Offr,Head of Dev
- Transaction
- Option Exercise
- Cost
- $0.00
- #Shares
- 51,172
- Value ($)
- 0
- #Shares Total
- 51,172
- Haller Julia AJun 15 '26Director
- Transaction
- Option Exercise
- Cost
- $53.76
- #Shares
- 20,460
- Value ($)
- 1,099,930
- #Shares Total
- 34,079
- Short Bartie WendyJun 03 '26EVP, Corporate Affairs
- Transaction
- Option Exercise
- Cost
- $0.00
- #Shares
- 8,040
- Value ($)
- 0
- #Shares Total
- 15,957
- Lenkowsky AdamMay 01 '26EVP, Chief Commercial Officer
- Transaction
- Option Exercise
- Cost
- $0.00
- #Shares
- 1,373
- Value ($)
- 0
- #Shares Total
- 20,508
